BioCryst Initiates Phase 1 Clinical Trial of Galidesivir
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the dosing of the first subject in a randomized, […]
Read moreHome » Medications »
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced the dosing of the first subject in a randomized, […]
Read more(HealthDay)—There is considerable variation in opioid prescribing among pediatric patients, according to a study published online Dec. 21 in JAMA Network Open. Daniel M. Tomaszewski, […]
Read moreEuropeans have found the secret to making some of the world’s costliest medicines much more affordable, as much as 80 percent cheaper than in the […]
Read moreNewspaper the Independent reported on the unusual trial in the UK. In relation to men who refused from amputation of the limb, which was developed […]
Read more(HealthDay)—About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, […]
Read moreThe contents Healthy drink No. 1: water Healthy drink No. 2: green and black tea Healthy drink No. 3: a decoction of rose hips Healthy […]
Read moreControl of blood sugar levels is extremely important for patients with diabetes. However, research has shown that many diabetics are needlessly checking sugar at home. […]
Read moreBritish researchers were able to unravel the mystery of red-haired people. They found as many as 8 genes that are responsible for hair color. British […]
Read moreSeniors and pregnant women must necessarily pass through flu shots before the New year. In the winter thousands of people of this category are most […]
Read moreScientists at Lund University (Sweden) conducted the first successful reprogramming of skin cells – as a result they were able to artificially create cells that […]
Read more